Company performance
Add to research
Current Price
as of Feb 13, 2025$282.12
P/E Ratio
47.97
Market Cap
$19.79B
Description
Add to research
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.
Metrics
Add to research
Overview
- HQActon, MA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerPODD
- Price$282.12+0.92%
Trading Information
- Market cap$19.79B
- Float99.45%
- Average Daily Volume (1m)547,536
- Average Daily Volume (3m)545,361
- EPS$6.01
Company
- Revenue$1.98B
- Rev growth (1yr)25.70%
- Net income$77.50M
- Gross margin70.12%
- EBITDA margin20.96%
- EBITDA$114.00M
- EV$17.71B
- EV/Revenue8.93
- P/E47.97
- P/S10.52
- P/B17.70
- Debt/Equity125.07
Documents
Add to research
SEC Filings
Earnings Calls